North America, Europe, And Asia Pacific ELISA Analyzers Market To Reach $681.98 Million By 2030

North America, Europe, And Asia Pacific ELISA Analyzers Market Growth And Trends

The North America, Europe, and Asia Pacific ELISA analyzers market size is expected to reach USD 681.98 million by 2030, registering a CAGR of 3.7% over the forecast period, according to a new report by Grand View Research, Inc. The market growth is supported by the increasing incidence of chronic diseases, increasing R&D activities to develop novel therapeutics & vaccines, and the development of novel ELISA-based products. Moreover, the favorable government initiative to adopt novel and effective testing options for better and more accurate diagnostic results is expected to fuel the demand for these analyzers. A wide range of ELISA applications in clinical diagnostics makes it suitable for hospitals & independent laboratories. The technology facilitates the use of monoclonal & polyclonal antibodies for the detection of specific antigenic molecules in tissues and aids in the rapid identification of tumor antigens.

Moreover, a large number of market players are offering ELISA-based tests and instruments for the diagnosis and screening of chronic & infectious diseases, which is expected to increase the growth. Advancements in medical devices and extensive utilization of immunoassay tests in point-of-care in vitro diagnostics, cancer diagnosis, therapeutic drug level monitoring, & infectious disease testing are factors likely to be responsible for the growth. ELISA is utilized for high-throughput screening of antibodies or drugs. The ELISA analyzer is anticipated to witness healthy growth due to its extensive test portfolio using immunoassay techniques coupled with affordable prices. The presence of a large number of pharmaceutical companies and the high penetration of clinical testing services to maintain the quality of therapeutic products are anticipated to increase market growth over the forecast period.

Scientists & researchers widely use ELISA microplate readers to save time for research & development activities. Moreover, the increasing adoption of technologically advanced and automated ELISA analyzers in drug development activities is reducing preclinical & clinical testing time with high accuracy. Market players are collaborating to introduce technologically advanced products across the globe. For instance, in August 2021, Novatec Immundiagnostica GmbH and Virotech Diagnostics GmbH merged and formed a new entity, Gold Standard Diagnostics Europe. The company is committed to continuing the research & development activities to develop novel high-quality assays and instruments to detect infectious and chronic diseases. It has expanded the company's product portfolio to include automated ELISA analyzers.

 Request a free sample copy or view report summary: North America, Europe, And Asia Pacific ELISA Analyzers Market Report

North America, Europe, And Asia Pacific ELISA Analyzers Market Report Highlights

• The optical grating segment held a considerable revenue share in 2022 due to the high market penetration of the technology

• The automated analyzers segment dominated the market in 2022 and is expected to register the fastest growth rate over the forecast period

• The vaccine development segment is projected to register the fastest CAGR over the forecast period owing to the rising R&D activities related to vaccine development for different chronic and infectious diseases

• The diagnostic laboratory segment held the largest market share in 2022 owing to highly sensitive, specific, scalable, & cost-effective tests of various types of samples

• Asia Pacific is expected to exhibit the fastest growth over the forecast period due to the increasing incidence of targeted diseases and high unmet healthcare needs in the region

North America, Europe, And Asia Pacific ELISA Analyzers Market Segmentation

Grand View Research has segmented the North America, Europe, and Asia Pacific ELISA analyzers market based on type, mode, application, end-user, and region:

North America, Europe, And Asia Pacific ELISA Analyzers Type Outlook (Revenue, USD Million, 2018 - 2030)

• Optical Filter ELISA Analyzers

• Optical Grating ELISA Analyzers

North America, Europe, And Asia Pacific ELISA Analyzers Mode Outlook (Revenue, USD Million, 2018 - 2030)

• Automated

• Semi-automated

North America, Europe, And Asia Pacific ELISA Analyzers Application Outlook (Revenue, USD Million, 2018 - 2030)

• Immunology

• Vaccine Development

• Drug Monitoring

• Others

North America, Europe, And Asia Pacific ELISA Analyzers End-user Outlook (Revenue, USD Million, 2018 - 2030)

• Biotechnology Companies

• Pharmaceutical Companies

• Contract Research Organization

• Diagnostic Laboratories

North America, Europe, And Asia Pacific ELISA Analyzers Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

• U.S.

• Canada

• Europe

• UK

• Germany

• France

• Italy

• Spain

• Denmark

• Sweden

• Norway

• Asia Pacific

• Japan

• China

• India

• South Korea

• Australia

• Thailand

List of Key Players of North America, Europe, And Asia Pacific ELISA Analyzers Market

• Thermo Fisher Scientific Inc.

• PerkinElmer Inc.

• Tecan Trading AG

• Agilent Technologies, Inc.

• VIRCELL S.L.

• VedaLab

• Dia.Pro Diagnostic Bioprobes S.r.l.

• ProGnosis Biotech SA

• RD-Ratio Diagnostics GmbH

• Gold Standard Diagnostics

• MEDICON HELLAS S.A.

• Human Gesellschaft für Biochemica & Diagnostica

• Institut Virion Serion GmbH

• Institute of Isotopes Co. Ltd.

• Trina Bioreactives AG

• Mabtech AB

• Abcam Plc.

• Miltenyi Biotec

• Novel Biomarkers Catalyst Labs

• Antibodies-online

• WILEX AG.

• Biorbyt

• Hycult Biotech